Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

Just released! Bladder cancer update from ESMO 25 📺 Prof. Thomas Powles shares his bladder cancer highlights & reviews the latest data from KEYNOTE-905, ALBAN & Imvigor011. This independent programme is supported by COR2ED

COR2EDMedEd's profile picture

COR2ED

1,616 subscribers

229,737 Aufrufe • vor 11 Monaten •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED
5:30

Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED

COR2ED

114,711 Aufrufe • vor 11 Monaten

Breast Cancer highlights from ASCO 2026! Dr Paolo Tarantino joined us at ASCO to share his expert insights on key trial data from ASCENT-03, ASCENT-04, TROPION-Breast02, SERENA-6, VIKTORIA-1, & OPTIMA How will these data impact clinical practice? 📺 Watch his update to find out! >> Programme endorsed by ICAN, International Cancer Advocacy Network This educational programme is supported by COR2ED
3:06

Breast Cancer highlights from ASCO 2026! Dr Paolo Tarantino joined us at ASCO to share his expert insights on key trial data from ASCENT-03, ASCENT-04, TROPION-Breast02, SERENA-6, VIKTORIA-1, & OPTIMA How will these data impact clinical practice? 📺 Watch his update to find out! >> Programme endorsed by ICAN, International Cancer Advocacy Network This educational programme is supported by COR2ED

COR2ED

2,492,255 Aufrufe • vor 3 Monaten

🚨Update from #ESMO24 Upper GI cancer data 🚨 Dr Lizzy Smyth & Dr Sam Klempner joined us at ESMO to share their insights into new #UpperGI cancer data & the potential impact on clinical practice. 📺 Watch their video update Supported by Bayer #MedEd #oncology #OncTwitter
2:35

🚨Update from #ESMO24 Upper GI cancer data 🚨 Dr Lizzy Smyth & Dr Sam Klempner joined us at ESMO to share their insights into new #UpperGI cancer data & the potential impact on clinical practice. 📺 Watch their video update Supported by Bayer #MedEd #oncology #OncTwitter

GI CONNECT powered by COR2ED

160,747 Aufrufe • vor 2 Jahren

Revisiting key data from ELCC 2026 📺 Prof. Nicolas Girard joined us at ELCC 2026 to review oncogene-addicted NSCLC data from Beamion LUNG-1, SOHO-01, IELCART & OptiTROP-Lung03 Programme endorsed by ICAN, International Cancer Advocacy Network, Biomarker Collaborative , Lung Cancer Europe , Exon 20 Group, a multistakeholder organization & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer
4:30

Revisiting key data from ELCC 2026 📺 Prof. Nicolas Girard joined us at ELCC 2026 to review oncogene-addicted NSCLC data from Beamion LUNG-1, SOHO-01, IELCART & OptiTROP-Lung03 Programme endorsed by ICAN, International Cancer Advocacy Network, Biomarker Collaborative , Lung Cancer Europe , Exon 20 Group, a multistakeholder organization & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

353,979 Aufrufe • vor 26 Tagen

Pre-analytical phase challenges & biomarker testing in HER2+ metastatic breast cancer From Prof. Gary Tse, Dr Carlos Barrios, & Oncology Brothers Highlights in this video 📹 >> Endorsed by Biomarker Collaborative Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.
5:46

Pre-analytical phase challenges & biomarker testing in HER2+ metastatic breast cancer From Prof. Gary Tse, Dr Carlos Barrios, & Oncology Brothers Highlights in this video 📹 >> Endorsed by Biomarker Collaborative Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

BREAST CANCER CONNECT powered by COR2ED

20,493,435 Aufrufe • vor 3 Monaten

ER+/HER2- metastatic breast cancer: Highlights from APBCS 2026 Satellite Symposium, chaired by Dr Mastura Md Yusof 📺 Experts discuss 2L+ treatment strategies in endocrine therapy-eligible patients From Dr Hope S. Rugo (Hope Rugo) and Prof. Matteo Lambertini (Matteo Lambertini, MD PhD) This programme has been sponsored by Menarini Stemline and is intended for HCPs only. Brought to you by COR2ED Medical Affairs
4:58

ER+/HER2- metastatic breast cancer: Highlights from APBCS 2026 Satellite Symposium, chaired by Dr Mastura Md Yusof 📺 Experts discuss 2L+ treatment strategies in endocrine therapy-eligible patients From Dr Hope S. Rugo (Hope Rugo) and Prof. Matteo Lambertini (Matteo Lambertini, MD PhD) This programme has been sponsored by Menarini Stemline and is intended for HCPs only. Brought to you by COR2ED Medical Affairs

COR2ED

7,632,504 Aufrufe • vor 6 Monaten

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim
5:45

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim

COR2ED

757,945 Aufrufe • vor 8 Monaten

#OnThisDayInWWE 20 years ago: John Tenta, best known as Earthquake, passes away from bladder cancer He is only 42 Sadly, his wife says no wrestlers, nor any officials, attend his funeral or send flowers 📺Dark Side of the Ring
4:47

#OnThisDayInWWE 20 years ago: John Tenta, best known as Earthquake, passes away from bladder cancer He is only 42 Sadly, his wife says no wrestlers, nor any officials, attend his funeral or send flowers 📺Dark Side of the Ring

On This Day in WWE

86,997 Aufrufe • vor 3 Monaten

Catch up on 𝘏𝘌𝘙2-mutant non-small cell lung cancer (NSCLC) data presented at ASCO 2026 Dr Herbert Loong, MBBS, FASCO & Dr Isabel Preeshagul joined us at ASCO 2026 to share their views on data emerging from the meeting 📺 Watch the video to get their expert insights on data from SOHO-01, Beamion LUNG-3, PRO results from the Beamion LUNG-1 trial, and advances in HER2 testing Programme endorsed by ICAN, International Cancer Advocacy Network, Biomarker Collaborative , Exon 20 Group, a multistakeholder organization & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer
4:40

Catch up on 𝘏𝘌𝘙2-mutant non-small cell lung cancer (NSCLC) data presented at ASCO 2026 Dr Herbert Loong, MBBS, FASCO & Dr Isabel Preeshagul joined us at ASCO 2026 to share their views on data emerging from the meeting 📺 Watch the video to get their expert insights on data from SOHO-01, Beamion LUNG-3, PRO results from the Beamion LUNG-1 trial, and advances in HER2 testing Programme endorsed by ICAN, International Cancer Advocacy Network, Biomarker Collaborative , Exon 20 Group, a multistakeholder organization & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

841,885 Aufrufe • vor 1 Monat

Lung cancer e-learning for HCPs Topic: the evolving TROP2-directed ADC landscape in metastatic NSCLC + strategies to optimise the treatment experience Endorsed by ICAN, International Cancer Advocacy Network, Exon 20 Group, a multistakeholder organization & Biomarker Collaborative Supported by an Independent Educational Grant from AstraZeneca 📹
1:15

Lung cancer e-learning for HCPs Topic: the evolving TROP2-directed ADC landscape in metastatic NSCLC + strategies to optimise the treatment experience Endorsed by ICAN, International Cancer Advocacy Network, Exon 20 Group, a multistakeholder organization & Biomarker Collaborative Supported by an Independent Educational Grant from AstraZeneca 📹

LUNG CONNECT powered by COR2ED

4,994,663 Aufrufe • vor 2 Monaten

Update from ESGO 2026 PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort Evaluating a first-in-class p53 reactivator, rezatapopt*, in TP53 Y220C–mutant advanced solid tumours 📺 Clinical insights and expert discussion from Profs Domenica Lorusso and Jean-Sebastien Frenel This programme has been sponsored by PMV Pharma and is intended for HCPs only. Brought to you by COR2ED Medical Affairs. *Rezatapopt is an investigational agent which is not approved by a regulatory agency
5:19

Update from ESGO 2026 PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort Evaluating a first-in-class p53 reactivator, rezatapopt*, in TP53 Y220C–mutant advanced solid tumours 📺 Clinical insights and expert discussion from Profs Domenica Lorusso and Jean-Sebastien Frenel This programme has been sponsored by PMV Pharma and is intended for HCPs only. Brought to you by COR2ED Medical Affairs. *Rezatapopt is an investigational agent which is not approved by a regulatory agency

COR2ED

5,788,637 Aufrufe • vor 6 Monaten

Explore the testing and treatment journey in 𝑁𝑇𝑅𝐾 fusion-positive lung cancer How can we use molecular testing to enable personalised care? 📺Find out in this educational video from Dr Herbert Loong (Herbert Loong, MBBS, FASCO) Endorsed by ICAN, International Cancer Advocacy Network & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer
5:27

Explore the testing and treatment journey in 𝑁𝑇𝑅𝐾 fusion-positive lung cancer How can we use molecular testing to enable personalised care? 📺Find out in this educational video from Dr Herbert Loong (Herbert Loong, MBBS, FASCO) Endorsed by ICAN, International Cancer Advocacy Network & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

1,829,879 Aufrufe • vor 2 Monaten

LEVIATHAN publication snapshot >> Expert insights on 2nd line treatment selection post atezolizumab + bevacizumab for HCC 📺 from Prof. David Pinato (David James Pinato 🇺🇦) >> Programme endorsed by European Liver Patients' Association, Blue Faery, Global Liver Institute & ESDO This programme is supported by an independent educational grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content.
4:29

LEVIATHAN publication snapshot >> Expert insights on 2nd line treatment selection post atezolizumab + bevacizumab for HCC 📺 from Prof. David Pinato (David James Pinato 🇺🇦) >> Programme endorsed by European Liver Patients' Association, Blue Faery, Global Liver Institute & ESDO This programme is supported by an independent educational grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content.

HCC CONNECT powered by COR2ED

701,773 Aufrufe • vor 8 Monaten

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer
1:07

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

2,703,909 Aufrufe • vor 2 Monaten

EP-NEC = distinct, aggressive subtype of neuroendocrine cancer Often has late diagnosis, frequent mis-categorisation, and mis-understanding Complexity & burden of EP-NEC increased by delays in diagnosis/pt confusion/inconsistent Tx pathways/limited specialist access How can pts thrive after EP-NEC diagnosis? 📺 Watch the video to find out From Jessica Thomas, Director of Patient Education at the Neuroendocrine Tumor Research Foundation Endorsed by Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim
4:51

EP-NEC = distinct, aggressive subtype of neuroendocrine cancer Often has late diagnosis, frequent mis-categorisation, and mis-understanding Complexity & burden of EP-NEC increased by delays in diagnosis/pt confusion/inconsistent Tx pathways/limited specialist access How can pts thrive after EP-NEC diagnosis? 📺 Watch the video to find out From Jessica Thomas, Director of Patient Education at the Neuroendocrine Tumor Research Foundation Endorsed by Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim

NET CONNECT powered by COR2ED

824,857 Aufrufe • vor 4 Monaten

Prof.Balaji Jagannathan, Professor & HOD, Medical Oncology, Govt Kalaignar Hospital, #Chennai, stabbed by 7 times by criminal from Peringalathur, whose mother ws being Rx fr stage 4 lung #Cancer at this hospital. Prof Balaji is very, very serious now. 🙏. #MedTwitter #medX
2:17

Prof.Balaji Jagannathan, Professor & HOD, Medical Oncology, Govt Kalaignar Hospital, #Chennai, stabbed by 7 times by criminal from Peringalathur, whose mother ws being Rx fr stage 4 lung #Cancer at this hospital. Prof Balaji is very, very serious now. 🙏. #MedTwitter #medX

Indian Doctor🇮🇳

64,421 Aufrufe • vor 1 Jahr